Reuters logo
in 4 months
BRIEF-Biovie receives FDA clearance for Phase 2A clinic trial in refractory ascites patients
April 3, 2017 / 1:24 PM / in 4 months

BRIEF-Biovie receives FDA clearance for Phase 2A clinic trial in refractory ascites patients

1 Min Read

April 3 (Reuters) - Biovie Inc:

* Biovie receives FDA clearance of IND application for phase 2a clinical trial in refractory ascites patients Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below